Published online before print July 15, 2002, doi: 10.1161/01.CIR.0000025636.03561.EE
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:820.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men
From the Center for Cardiovascular Disease Prevention (A.D.P., N.R., P.M.R.), the Leducq Center for Molecular and Genetic Epidemiology of Cardiovascular Disorders (A.D.P., N.R., P.M.R.), the Divisions of Cardiology (A.D.P., P.M.R.) and Preventive Medicine (A.D.P., P.M.R.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass; and the Department of Pathology (N.R.), Children’s Hospital Medical Center and Harvard Medical School, Boston, Mass.
Correspondence to Dr Paul M. Ridker, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Ave E, Boston, MA 02115-1204. E-mail pridker{at}partners.org
Background— Elevated levels of soluble cellular adhesion molecules have been linked to the development of occlusive coronary events in otherwise healthy individuals. It is not certain, however, whether similar relationships exist for the development of early systemic atherosclerosis.
Methods and Results— In a prospective, nested case-control study conducted among 14 916 middle-aged men, we evaluated the relationship between baseline levels of soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and the subsequent development of symptomatic peripheral arterial disease (PAD) during a 9-year follow-up period. Median levels of sICAM-1 but not sVCAM-1 were significantly higher at baseline among men who developed PAD than among those who did not (285.2 versus 267.8 ng/mL [P=0.005] for sICAM-1 and 701.0 versus 709.3 ng/mL [P=0.8] for sVCAM-1). In analyses adjusted for age and smoking, the odds ratio in the highest compared with the lowest quartile of sICAM-1 was 3.9 (95% CI 1.7 to 8.6; Ptrend=0.001). After additional adjustment for lipid and nonlipid risk factors, including C-reactive protein, elevated sICAM-1 remained significantly associated with subsequent PAD (OR 3.5, 95% CI 1.4 to 8.5, Ptrend=0.008). Whereas a monotonic dose-response relationship was evident over the full spectrum of ICAM-1 levels, elevated sVCAM-1 was not associated with future PAD in either age- and smoking-adjusted or fully adjusted models.
Conclusions— Elevated levels of sICAM-1 are independently associated with the development of accelerated atherosclerosis among otherwise healthy men even in the absence of acute coronary occlusion.
Key Words: cell adhesion molecules • peripheral vascular disease • men
This article has been cited by other articles:
 |
|
 |
|
  F. J Khawaja and I. J Kullo Novel markers of peripheral arterial disease Vascular Medicine, November 1, 2009; 14(4): 381 - 392. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Doupis, T. E. Lyons, S. Wu, C. Gnardellis, T. Dinh, and A. Veves Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2157 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sam, S. Haffner, M. H. Davidson, R. B. D'Agostino Sr., S. Feinstein, G. Kondos, A. Perez, and T. Mazzone Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes Diabetes Care, May 1, 2009; 32(5): 932 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, R. J. Glynn, N. Rifai, J. E. Manson, P. M. Ridker, D. M. Nathan, and D. A. Schaumberg Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial Diabetes Care, December 1, 2008; 31(12): 2338 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Khaleghi, Z. Ali, T. H. Mosley Jr., S. T. Turner, and I. J. Kullo Association of Soluble Cell Adhesion Molecules with Ankle-Brachial Index in a Biethnic Cohort of Predominantly Hypertensive Individuals Clin. Chem., November 1, 2008; 54(11): 1788 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Pande, T. S. Perlstein, J. A. Beckman, and M. A. Creager Association of Insulin Resistance and Inflammation With Peripheral Arterial Disease: The National Health and Nutrition Examination Survey, 1999 to 2004 Circulation, July 1, 2008; 118(1): 33 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Pradhan, S. Shrivastava, N. R. Cook, N. Rifai, M. A. Creager, and P. M Ridker Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk Circulation, February 12, 2008; 117(6): 823 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Nettleton, L. M Steffen, M. B Schulze, N. S Jenny, R G. Barr, A. G Bertoni, and D. R Jacobs Jr Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA) Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1615 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M S O'Neill, A Veves, J A Sarnat, A Zanobetti, D R Gold, P A Economides, E S Horton, and J Schwartz Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility Occup. Environ. Med., June 1, 2007; 64(6): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Jimenez, R. M. Estepa, R. M. Camacho, R. C. Estrada, F. G. Luna, and F. B. Guitarte Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children Eur. J. Endocrinol., April 1, 2007; 156(4): 497 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Nettleton, L. M Steffen, E. J Mayer-Davis, N. S Jenny, R. Jiang, D. M Herrington, and D. R Jacobs Jr Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA) Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1369 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Brevetti, V. Schiano, and M. Chiariello Cellular adhesion molecules and peripheral arterial disease Vascular Medicine, February 1, 2006; 11(1): 39 - 47. [Abstract] [PDF]
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study Circulation, August 16, 2005; 112(7): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Danielsson, L Truedsson, K-F Eriksson, and L Norgren Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus Vascular Medicine, August 1, 2005; 10(3): 191 - 198. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. Seddon, S. George, B. Rosner, and N. Rifai Progression of Age-Related Macular Degeneration: Prospective Assessment of C-Reactive Protein, Interleukin 6, and Other Cardiovascular Biomarkers Arch Ophthalmol, June 1, 2005; 123(6): 774 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Herron, C. Rao, S. Liu, L. Laprade, J. A. Richardson, E. Olivieri, C. Semsarian, S. E. Millar, L. Stubbs, and D. R. Beier A mutation in NFkB interacting protein 1 results in cardiomyopathy and abnormal skin development in wa3 mice Hum. Mol. Genet., March 1, 2005; 14(5): 667 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Register, K. P. Burdon, L. Lenchik, D. W. Bowden, G. A. Hawkins, B. J. Nicklas, K. Lohman, F.-C. Hsu, C. D. Langefeld, and J. J. Carr Variability of Serum Soluble Intercellular Adhesion Molecule-1 Measurements Attributable to a Common Polymorphism Clin. Chem., November 1, 2004; 50(11): 2185 - 2187. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zouridakis, P. Avanzas, R. Arroyo-Espliguero, S. Fredericks, and J. C. Kaski Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris Circulation, September 28, 2004; 110(13): 1747 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Endemann and E. L. Schiffrin Endothelial Dysfunction J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1983 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Keaney Jr, J. M. Massaro, M. G. Larson, R. S. Vasan, P. W. F. Wilson, I. Lipinska, D. Corey, P. Sutherland, J. A. Vita, and E. J. Benjamin Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study J. Am. Coll. Cardiol., July 7, 2004; 44(1): 168 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Baer, J. T Judd, B. A Clevidence, and R. P Tracy Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study Am. J. Clinical Nutrition, June 1, 2004; 79(6): 969 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lutgens, R.-J. van Suylen, B. C. Faber, M. J. Gijbels, P. M. Eurlings, A.-P. Bijnens, K. B. Cleutjens, S. Heeneman, and M. J.A.P. Daemen Atherosclerotic Plaque Rupture: Local or Systemic Process? Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2123 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Perez, C. Q. Huang, J. R. Johnson, B. J. Gallay, M. M. Gandhi, J. P. McVicar, and C. Troppmann Pretransplantation Soluble Adhesion Molecule Expression Predicts Outcome After Living Donor Renal Transplantation Arch Surg, October 1, 2003; 138(10): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin and R. M. Touyz Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade J. Am. Coll. Cardiol., September 3, 2003; 42(5): 911 - 913. [Full Text] [PDF]
|
|
|
|
|
|
O. Hamdy, S. Ledbury, C. Mullooly, C. Jarema, S. Porter, K. Ovalle, A. Moussa, A. Caselli, A. E. Caballero, P. A. Economides, et al. Lifestyle Modification Improves Endothelial Function in Obese Subjects With the Insulin Resistance Syndrome Diabetes Care, July 1, 2003; 26(7): 2119 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsong Tan and A. D. Blann To stroke or not to stroke: Is ICAM-1 or CRP the answer? Neurology, June 24, 2003; 60(12): 1884 - 1885. [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Maurus, D. Schmidt, M. K.J. Schneider, M. I. Turina, J. D. Seebach, and G. Zund Hypoxia and reoxygenation do not upregulate adhesion molecules and natural killer cell adhesion on human endothelial cells in vitro Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ballantyne and M. L. Entman Soluble Adhesion Molecules and the Search for Biomarkers for Atherosclerosis Circulation, August 13, 2002; 106(7): 766 - 767. [Full Text] [PDF]
|
|